Mankind Pharma Limited (BOM:543904)
2,469.90
-107.05 (-4.15%)
At close: Jul 31, 2026
Mankind Pharma Revenue
Mankind Pharma had revenue of 40.31B INR in the quarter ending June 30, 2026, with 12.89% growth. This brings the company's revenue in the last twelve months to 147.38B, up 14.16% year-over-year. In the fiscal year ending March 31, 2026, Mankind Pharma had annual revenue of 142.78B with 16.96% growth.
Revenue (ttm)
147.38B
Revenue Growth
+14.16%
P/S Ratio
6.92
Revenue / Employee
7.21M
Employees
20,451
Market Cap
1.02T
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 142.78B | 20.70B | 16.96% |
| Mar 31, 2025 | 122.07B | 19.47B | 18.98% |
| Mar 31, 2024 | 102.60B | 15.11B | 17.27% |
| Mar 31, 2023 | 87.49B | 9.68B | 12.44% |
| Mar 31, 2022 | 77.82B | 15.67B | 25.22% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Dr. Reddy's Laboratories | 331.19B |
| Lupin | 279.58B |
| Torrent Pharmaceuticals | 157.23B |
| Jubilant Pharmova | 82.80B |
| Abbott India | 69.29B |
| Granules India | 56.32B |
| J. B. Chemicals & Pharmaceuticals | 41.48B |
| GlaxoSmithKline Pharmaceuticals | 38.22B |
Mankind Pharma News
- 3 days ago - Mankind Pharma Transcript: Q1 26/27 - Transcripts
- 3 days ago - Mankind Pharma Quarterly report: Q1 2027 - Filings
- 3 days ago - Mankind Pharma Slides: Q1 2027 - Filings
- 2 months ago - Mankind Pharma Transcript: Q4 25/26 - Transcripts
- 2 months ago - Mankind Pharma Quarterly report: Q4 2026 - Filings
- 2 months ago - Mankind Pharma Slides: Q4 2026 - Filings
- 2 months ago - Mankind Pharma Annual report: Q4 2026 - Filings
- 6 months ago - Mankind Pharma Transcript: Q3 25/26 - Transcripts